Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes

被引:0
作者
Shi Tai
Liyao Fu
Ningjie Zhang
Rukai Yang
Yuying Zhou
Zhenhua Xing
Yongjun Wang
Shenghua Zhou
机构
[1] The Second Xiangya Hospital of Central South University,Department of Cardiovascular Medicine
[2] The Second Xiangya Hospital of Central South University,Department of Blood Transfusion
[3] The Xiangtan Central Hospital,Department of Cardiology
来源
Cardiovascular Diabetology | / 21卷
关键词
Triglyceride-glucose index; Cumulative exposure; Major adverse cardiovascular events; Insulin resistance; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 258 条
[1]  
Wiviott SD(2022)10. Cardiovascular disease and risk management: standards of medical care in diabetes-2022 Diabetes Care 45 S144-S174
[2]  
Raz I(2019)Dapagliflozin and cardiovascular outcomes in type 2 diabetes N Engl J Med 380 347-357
[3]  
Bonaca MP(2017)Canagliflozin and cardiovascular and renal events in type 2 diabetes N Engl J Med 377 644-657
[4]  
Mosenzon O(2015)Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes N Engl J Med 373 2117-2128
[5]  
Kato ET(2018)Economic costs of diabetes in the US in 2017 Diabetes Care 41 917-928
[6]  
Cahn A(2021)Insulin resistance, cardiovascular stiffening and cardiovascular disease Metabolism 119 1357-1364
[7]  
Silverman MG(2020)Diabetes and coronary artery disease: not just a risk factor Heart 106 2180-2184
[8]  
Zelniker TA(2000)Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus Circulation 102 2-42
[9]  
Kuder JF(2014)Assessment of pancreatic beta-cell function: review of methods and clinical applications Curr Diabetes Rev 10 108-304
[10]  
Murphy SA(2020)Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China Cardiovasc Diabetol 19 299-105